GENTICEL
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus infections and virus-induced diseases. Genticel aims to become a leader in immunotherapy in multiple indications, starting with HPV and HPV induced diseases such as cervical cancer.
GENTICEL
Social Links:
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2001-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.genticel.com
Total Employee:
11+
Status:
Closed
Contact:
+33 5 61 28 70 60
Total Funding:
41.38 M USD
Technology used in webpage:
Domain Not Resolving Adobe Dreamweaver
Current Employees Featured
Founder
Investors List
Andera Partners
Andera Partners investment in Series D - Genticel
InnoBio Fund
InnoBio Fund investment in Series D - Genticel
Idinvest Partners
Idinvest Partners investment in Series D - Genticel
Wellington Partners
Wellington Partners investment in Series D - Genticel
Amundi Private Equity Funds
Amundi Private Equity Funds investment in Series D - Genticel
Andera Partners
Andera Partners investment in Series C - Genticel
InnoBio Fund
InnoBio Fund investment in Series C - Genticel
Amundi Private Equity Funds
Amundi Private Equity Funds investment in Series C - Genticel
Idinvest Partners
Idinvest Partners investment in Series C - Genticel
More informations about "Genticel"
Genticel Company Profile - Office Locations, Competitors ... - Craft
Genticel Société Anonyme, a clinical stage biotechnology company, develops immunotherapies to prevent cancers caused by the human papillomavirus (HPV). The company develops GTL001, …See details»
Genticel: Contact Details and Business Profile - RocketReach
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus …See details»
Genticel S.A. - Ownership and Business Overview - Mergr
Genticel S.A. is a biotechnology company specialized in the development of a vaccine against infection responsible for uterin cancers. Genticel was formed in 2001 and is based in Labège …See details»
Genticel | Labège, Midi-Pyrénées, France Startup
Genticel is a clinical stage biotechnology company focused on developing multivalent vaccines against Human Papillomavirus (HPV) infections which are the known cause for several …See details»
Genticel Company Profile 2024: Valuation, Investors, Acquisition ...
Genticel General Information Description. Genkyotex SA is a biopharmaceutical company. It is engaged in the business of research, study, manufacturing and distribution of medicines, drug …See details»
Genticel S.A. - Labège, France - bionity.com
Genticel is currently advancing a pipeline of therapeutic vaccines candidates for millions of HPV infected women. 93 million women are infected with HPV 16 and/or HPV 18 types, responsible …See details»
Genticel Overview | SignalHire Company Profile
Its headquarters is located at Labege, Other, FR. The Genticel annual revenue is estimated at < 1M. Total funding of the company - $41.3M. ... To connect with Genticel employee register on …See details»
Genticel Headquarters and Office Locations - Craft.co
Genticel Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Genticel is headquartered in Labège, 516 Rue Pierre …See details»
Genticel - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Genticel . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Genticel has 1 …See details»
Genticel - Products, Competitors, Financials, Employees, …
Genticel SA GTCL Financial and Strategic SWOT Analysis Review Report Updated 28092018 Prices from USD $300. Sep 30, 2018. 13:02 EDT 30 Sep 2018 | BioPortfolio Reports …See details»
Genticel - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 24, 2013: Series D - …See details»
Genticel : Genticel becomes Genkyotex - MarketScreener
Feb 28, 2017 The new group's organization chart. From today, the Company's corporate name and trading name (“Genticel” prior to the General Meeting) is “Genkyotex”. To avoid the risk of …See details»
Genticel | Golden
Canonical knowledge wiki about Genticel. Canonical knowledge wiki about Genticel. ... Read about it here Genticel. Overview Structured Data Issues Contributors Activity. Contents. …See details»
Genticel - VentureRadar
Genticel develops therapeutic vaccines for women already infected by the human papillomavirus (HPV) before high grade lesions or cervical cancer occur. VentureRadar Research / Company …See details»
Dr. Sophie Olivier appointed as chief medical officer of Genticel …
May 17, 2020 Genticel has recruited Dr. Sophie Olivier as chief medical officer to lead the clinical development of its pipeline, in particular the ProCervix phase II trial. ... Recent …See details»
Genticel - Crunchbase
Companies like Genticel include Carisma Therapeutics, Chimeron Bio, and Spero Therapeutics. Echo Therapeutics Philadelphia , Pennsylvania , United States 11-50 employeesSee details»
Genticel Definition - Law Insider
Genticel or the “Company” refers to Genkyotex (formerly Genticel), a limited company (société anonyme) with shares admitted to trading on the Euronext Paris and Euronext Brussels …See details»
Genticel - Manufacturing Chemist
Genticel licenses Vaxiclase platform to Serum Institute of India for use in whooping cough vaccines. Agreement entitles Genticel to up to US$57m in upfront and milestones payments …See details»
Genticel - cosmeticsbusiness.com
Genticel. Genticel. Visit website. Profile. Share; X; LinkedIn; Facebook; Become a Subscriber. Through digital, live and print products, Cosmetics Business informs and inspires business …See details»